000056155 001__ 56155
000056155 005__ 20200221144346.0
000056155 0247_ $$2doi$$a10.1186/s12875-016-0464-5
000056155 0248_ $$2sideral$$a95274
000056155 037__ $$aART-2016-95274
000056155 041__ $$aeng
000056155 100__ $$aGumà-Uriel, L.
000056155 245__ $$aImpact of IPDE-SQ personality disorders on the healthcare and societal costs of fibromyalgia patients: A cross-sectional study
000056155 260__ $$c2016
000056155 5060_ $$aAccess copy available to the general public$$fUnrestricted
000056155 5203_ $$aBackground: Data is lacking on comorbid personality disorders (PD) and fibromyalgia syndrome (FMS) in terms of prevalence, and associated healthcare and societal costs. The main aim of this study was to assess the prevalence of PD in FMS patients and to analyse whether the presence of comorbid PD is related to worse functional impairment and greater healthcare (medical visits, drug consumption, and medical tests) and societal costs. Methods: A cross-sectional study was performed using the baseline data of 216 FMS patients participating in a randomized, controlled trial carried out in three primary health care centres situated in the region of Barcelona, Spain. Measurement instruments included the International Personality Disorder Examination - Screening Questionnaire (IPDE-SQ), the Fibromyalgia Impact Questionnaire (FIQ), the Client Service Receipt Inventory (CSRI), and a socio-demographic questionnaire. Results: Most patients (65 %) had a potential PD according to the IPDE-SQ. The most prevalent PD were the avoidant (41.4 %), obsessive-compulsive (33.1 %), and borderline (27 %). We found statistically significant differences in functional impairment (FIQ scores) between FMS patients with potential PD vs non-PD (59.2 vs 51.1; p < 0.001). Multivariate regression analyses revealed that higher FIQ total scores and the presence of potential PD were related to more healthcare costs (primary and specialised care visits). Conclusions: As expected, PD are frequent comorbid conditions in patients with FMS. Our results suggest that the screening of comorbid PD in patients with FMS might be recommendable in order to detect potential frequent attenders to primary and specialised care.
000056155 536__ $$9info:eu-repo/grantAgreement/ES/ISCIII/CP14-00087
000056155 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/
000056155 590__ $$a1.751$$b2016
000056155 591__ $$aMEDICINE, GENERAL & INTERNAL$$b61 / 154 = 0.396$$c2016$$dQ2$$eT2
000056155 591__ $$aPSYCHOLOGY$$b9 / 20 = 0.45$$c2016$$dQ2$$eT2
000056155 591__ $$aPSYCHIATRY$$b9 / 20 = 0.45$$c2016$$dQ2$$eT2
000056155 592__ $$a1.095$$b2016
000056155 593__ $$aFamily Practice$$c2016$$dQ1
000056155 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000056155 700__ $$aPeñarrubia-María, M.T.
000056155 700__ $$aCerdà-Lafont, M.
000056155 700__ $$aCunillera-Puertolas, O.
000056155 700__ $$aAlmeda-Ortega, J.
000056155 700__ $$aFernández-Vergel, R.
000056155 700__ $$0(orcid)0000-0002-3797-4218$$aGarcía-Campayo, J.$$uUniversidad de Zaragoza
000056155 700__ $$aLuciano, J.V.
000056155 7102_ $$11007$$2745$$aUniversidad de Zaragoza$$bDpto. Medicina, Psiqu. y Derm.$$cArea Psiquiatría
000056155 773__ $$g17, 1 (2016), [10 pp]$$pBMC Family Practice$$tBMC Family Practice$$x1471-2296
000056155 8564_ $$s788897$$uhttps://zaguan.unizar.es/record/56155/files/texto_completo.pdf$$yVersión publicada
000056155 8564_ $$s100165$$uhttps://zaguan.unizar.es/record/56155/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000056155 909CO $$ooai:zaguan.unizar.es:56155$$particulos$$pdriver
000056155 951__ $$a2020-02-21-13:52:36
000056155 980__ $$aARTICLE